tiprankstipranks
Trending News
More News >
Sensei Biotherapeutics, Inc. (DE:407)
:407
Germany Market

Sensei Biotherapeutics (407) Income Statement

Compare
1 Followers

Sensei Biotherapeutics Income Statement

Last quarter (Q4 2024), Sensei Biotherapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Sensei Biotherapeutics's net income was $-7.77M. See Sensei Biotherapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -571.00K$ -1.81M$ -685.00K$ -209.00K
Operating Expenses
$ 32.61M$ 37.06M$ 50.19M$ 37.48M$ 18.71M
Depreciation and Amortization
$ -2.37M$ 3.68M$ 1.81M$ 685.00K$ 209.00K
EBITDA
$ -32.61M$ -33.39M$ -46.56M$ -36.80M$ -18.50M
Operating Income
$ -32.61M$ -37.06M$ -50.19M$ -37.48M$ -19.45M
Other Income/Expenses
$ 2.46M$ 2.96M$ 1.60M$ 688.00K$ -649.00K
Pretax Income
$ -30.16M$ -34.10M$ -48.59M$ -36.79M$ -20.10M
Net Income
$ -30.16M$ -34.10M$ -48.81M$ -37.46M$ -20.63M
Per Share Metrics
Basic EPS
$ -1.20$ -1.22$ -1.59$ -1.35$ -0.67
Diluted EPS
$ -1.20$ -1.22$ -1.59$ -1.35$ -0.67
Weighted Average Shares Outstanding
25.12M 27.95M 30.70M 27.71M 30.59M
Weighted Average Shares Outstanding (Diluted)
25.12M 27.95M 30.70M 27.71M 30.59M
Currency in USD

Sensei Biotherapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis